ALBANJI, M.H. et al. 2025. IMMUNOPATHOGENESIS AND EMERGING IMMUNOTHERAPIES IN TYPE 1 DIABETES MELLITUS: THE ROLE OF TEPLIZUMAB IN DISEASE MODULATION. TPM – Testing, Psychometrics, Methodology in Applied Psychology. 32, S1 (2025): Posted 12 May (Aug. 2025), 738–744.